Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 500

1.

Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives.

Song JM, Park KD, Lee KH, Byun YH, Park JH, Kim SH, Kim JH, Seong BL.

Antiviral Res. 2007 Nov;76(2):178-85.

PMID:
17709148
2.

In vitro anti-influenza virus and anti-inflammatory activities of theaflavin derivatives.

Zu M, Yang F, Zhou W, Liu A, Du G, Zheng L.

Antiviral Res. 2012 Jun;94(3):217-24. doi: 10.1016/j.antiviral.2012.04.001.

PMID:
22521753
3.

Antiviral effect of catechins in green tea on influenza virus.

Song JM, Lee KH, Seong BL.

Antiviral Res. 2005 Nov;68(2):66-74.

PMID:
16137775
4.

Mechanisms of the action of povidone-iodine against human and avian influenza A viruses: its effects on hemagglutination and sialidase activities.

Sriwilaijaroen N, Wilairat P, Hiramatsu H, Takahashi T, Suzuki T, Ito M, Ito Y, Tashiro M, Suzuki Y.

Virol J. 2009 Aug 13;6:124. doi: 10.1186/1743-422X-6-124.

5.

Anti-influenza virus activity of green tea by-products in vitro and efficacy against influenza virus infection in chickens.

Lee HJ, Lee YN, Youn HN, Lee DH, Kwak JH, Seong BL, Lee JB, Park SY, Choi IS, Song CS.

Poult Sci. 2012 Jan;91(1):66-73. doi: 10.3382/ps.2011-01645.

PMID:
22184430
6.

Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro.

Nguyen JT, Hoopes JD, Le MH, Smee DF, Patick AK, Faix DJ, Blair PJ, de Jong MD, Prichard MN, Went GT.

PLoS One. 2010 Feb 22;5(2):e9332. doi: 10.1371/journal.pone.0009332.

7.

Influenza virus susceptibility and resistance to oseltamivir.

Aoki FY, Boivin G, Roberts N.

Antivir Ther. 2007;12(4 Pt B):603-16. Review.

PMID:
17944268
8.

Pomegranate (Punica granatum) purified polyphenol extract inhibits influenza virus and has a synergistic effect with oseltamivir.

Haidari M, Ali M, Ward Casscells S 3rd, Madjid M.

Phytomedicine. 2009 Dec;16(12):1127-36. doi: 10.1016/j.phymed.2009.06.002.

PMID:
19586764
9.

Mechanism of the antiviral effect of hydroxytyrosol on influenza virus appears to involve morphological change of the virus.

Yamada K, Ogawa H, Hara A, Yoshida Y, Yonezawa Y, Karibe K, Nghia VB, Yoshimura H, Yamamoto Y, Yamada M, Nakamura K, Imai K.

Antiviral Res. 2009 Jul;83(1):35-44. doi: 10.1016/j.antiviral.2009.03.002.

PMID:
19501255
10.

Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants.

Ilyushina NA, Bovin NV, Webster RG, Govorkova EA.

Antiviral Res. 2006 Jul;70(3):121-31.

PMID:
16516984
11.

Different neuraminidase inhibitor susceptibilities of human H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany from 2001 to 2005/2006.

Bauer K, Richter M, Wutzler P, Schmidtke M.

Antiviral Res. 2009 Apr;82(1):34-41. doi: 10.1016/j.antiviral.2009.01.006.

PMID:
19428593
12.

Broad-spectrum antiviral effect of Agrimonia pilosa extract on influenza viruses.

Shin WJ, Lee KH, Park MH, Seong BL.

Microbiol Immunol. 2010;54(1):11-9. doi: 10.1111/j.1348-0421.2009.00173.x.

13.

Oseltamivir boosts 2009 H1N1 virus infectivity in vitro.

Lin X, Zhou J, Zhang Y, Wu J, Zhang F, Li Z, Zhang Y, Bi S, Shu Y, Wang Y.

Biochem Biophys Res Commun. 2009 Dec 25;390(4):1305-8. doi: 10.1016/j.bbrc.2009.10.142.

PMID:
19879239
14.

Amantadine- and oseltamivir-resistant variants of influenza A viruses in Thailand.

Bai GR, Chittaganpitch M, Kanai Y, Li YG, Auwanit W, Ikuta K, Sawanpanyalert P.

Biochem Biophys Res Commun. 2009 Dec 18;390(3):897-901. doi: 10.1016/j.bbrc.2009.10.071.

PMID:
19850010
15.

In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses.

Sleeman K, Mishin VP, Deyde VM, Furuta Y, Klimov AI, Gubareva LV.

Antimicrob Agents Chemother. 2010 Jun;54(6):2517-24. doi: 10.1128/AAC.01739-09.

16.

Neuraminidase inhibitor susceptibility of porcine H3N2 influenza A viruses isolated in Germany between 1982 and 1999.

Bauer K, Schrader C, Suess J, Wutzler P, Schmidtke M.

Antiviral Res. 2007 Sep;75(3):219-26.

PMID:
17445913
17.

Inhibition of influenza virus replication by plant-derived isoquercetin.

Kim Y, Narayanan S, Chang KO.

Antiviral Res. 2010 Nov;88(2):227-35. doi: 10.1016/j.antiviral.2010.08.016.

PMID:
20826184
18.

Design, synthesis, and in vitro biological evaluation of 1H-1,2,3-triazole-4-carboxamide derivatives as new anti-influenza A agents targeting virus nucleoprotein.

Cheng H, Wan J, Lin MI, Liu Y, Lu X, Liu J, Xu Y, Chen J, Tu Z, Cheng YS, Ding K.

J Med Chem. 2012 Mar 8;55(5):2144-53. doi: 10.1021/jm2013503.

PMID:
22332894
19.
20.

Germacrone inhibits early stages of influenza virus infection.

Liao Q, Qian Z, Liu R, An L, Chen X.

Antiviral Res. 2013 Dec;100(3):578-88. doi: 10.1016/j.antiviral.2013.09.021.

PMID:
24095670

Supplemental Content

Support Center